Implantable cardioverter defibrillator.
Conditions
Interventions
None listed
Sponsors
Amsterdam University Medical Centers (AUMC)
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - ICD or CRT-D implantation for either primary or secondary prevention less than 5 years prior to enrolment; - Participation in the remote monitoring program at AUMC or RIGS; - Patients =18 years old - Having received appropriate or inappropriate ICD therapy or proof of ventricular arrhythmias in the last 8 years prior to enrolment
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation for both the development-study and feasibility-study: - Unwilling to participate; - Study participants with a life expectancy of less than one year; - Study participants with circumstances that prevent follow-up (emigration, change of hospital for follow-up, dropping out of the remote monitoring program); - Study participants who are unable to wear the accelerometer wrist-band (e.g. allergic to the material); - Clinically unstable study participants; - End-stage of heart failure (NYHA-class IV); - Study participants unable to complete a questionnaire; - Does not understand the local language (Dutch or Danish); - Serious physical disability (e.g. wheelchair-bound); - A planned ablation for ventricular tachycardia (VT); - Significant movement disorder (i.e. hemiplegia or Parkinson’s disease or similar).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICD therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality, MACE, hospitalization, SVT onset, quality of life | — |
Contacts
Public ContactMaarten Kolk
Amsterdam UMC
Outcome results
None listed